For the Inventor, By the Inventor

Enter assignee name

Sanofi

USPTO Granted Patents = 1,543

% Expired Patents = 24.2

CIPO Patents = 59

EPO Patents = 854

Trademarks = 105

Forward Citations = 8,140

Loading Chart...

Loading Chart...

2,067 inventors (with patents filed for the assignee):

Matthew Meredith Jones (50 out of 81 patents)

Anthony Paul Morris (47 out of 73 patents)

Dieter Kadereit (41 out of 57 patents)

4. Michael Helmer (38 out of 93 patents)

5. Torsten Haack (33 out of 34 patents)

6. Siegfried Stengelin (33 out of 62 patents)

7. David Aubrey Plumptre (32 out of 206 patents)

8. Andreas Evers (31 out of 33 patents)

9. Robert Boigegrain (30 out of 37 patents)

10. Vincenzo Proietto (30 out of 47 patents)

11. Michael Wagner (28 out of 38 patents)

12. Xavier Emonds-Alt (28 out of 46 patents)

13. Michael Schabbach (27 out of 89 patents)

14. Didier Van Broeck (27 out of 40 patents)

15. Michael Jugl (26 out of 81 patents)

Core Competencies:

Drug Delivery Device

Infusion Mechanism

Antibody Therapies

Wearable Sensors

Injection Device

Combination Therapies

Chemical Compounds

Data Collection Apparatus

Patient Care Improvement

Therapeutic Applications

Polypeptides

Immunoglobulin Domains

1,543 patents: Sort by Forward Citations

1. 12747487 - COMPOSITIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF USING SAME (2026-09-29),

2. 12746344 - Cartridge assembly for a drug delivery device and drug delivery device (2026-09-29),

3. 12745956 - Wearable medical device (2026-09-29),

4. 12735397 - IL-17A modulators (2026-09-15),

5. 12734304 - Modular system for a drug delivery device with electronic and corresponding modules and method (2026-09-15),

6. 12734303 - Switch assembly for an electronic system of a drug delivery device (2026-09-15),

7. 12728207 - Injector device with distraction mechanism (2026-09-08),

8. 12723106 - PROTEASE-PROCESSED MOLECULES (2026-09-01),

9. 12723072 - Immunoglobulin variable domains (2026-09-01),

10. D1144427 - Display screen with a graphical user interface (2026-08-25),

11. 12718711 - Electronic label for a drug delivery device (2026-08-25),

12. 12714361 - Medical devices and methods for administering basal insulin dose and bolus insulin dose (2026-08-25),

13. D1142496 - DISPLAY SCREEN WITH AN ANIMATED COMPUTER ICON (2026-08-18),

14. D1142446 - DISPLAY SCREEN WITH A GRAPHICAL USER INTERFACE (2026-08-18),

15. D1142445 - DISPLAY SCREEN WITH A GRAPHICAL USER INTERFACE (2026-08-18),

Sanofi is a global healthcare leader based in Paris, specializing in the development and manufacturing of innovative drug delivery devices. The company focuses on advanced technologies in drug delivery mechanisms, including infusion systems and injection devices, to enhance patient care. Sanofi is also engaged in research on antibody therapies, wearable sensors, and combination therapies, aiming to improve treatment outcomes through effective delivery of chemical compounds and data collection apparatus. Its commitment to innovation positions it at the forefront of the pharmaceutical industry.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

1,543 Patents

#9 in Paris

#16 in France

#641 in the World

Sanofi

Forward Citations = 8,140

2,067 inventors:

Matthew Meredith Jones (50 out of 81 patents)

Anthony Paul Morris (47 out of 73 patents)

Dieter Kadereit (41 out of 57 patents)

4. Michael Helmer (38 out of 93 patents)

5. Torsten Haack (33 out of 34 patents)

Please report any incorrect information to [email protected]

Loading…